Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
sergio.valente@uniroma1.it
Sergio Valente
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
sergio.valente@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Effects of class II-selective histone deacetylase inhibitor on neuromuscular function and disease progression in SOD1-ALS mice
NEUROSCIENCE
2018
Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells
PHILOSOPHICAL TRANSACTIONS - ROYAL SOCIETY. BIOLOGICAL SCIENCES
2018
Trends of LSD1 inhibitors in viral infections
FUTURE MEDICINAL CHEMISTRY
2018
Combined HAT/EZH2 modulation leads to cancer-selective cell death
ONCOTARGET
2018
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia
ONCOTARGET
2018
Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers
PSYCHOPHARMACOLOGY
2018
Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS
AGING CELL
2018
A quinoline-based DNA methyltransferase inhibitor as a possible adjuvant in osteosarcoma therapy
MOLECULAR CANCER THERAPEUTICS
2018
Six years (2012-2018) of researches on catalytic EZH2 inhibitors: the boom of the 2-pyridone compounds
THE CHEMICAL RECORD
2018
Application of Small Epigenetic Modulators in Pediatric Medulloblastoma
FRONTIERS IN PEDIATRICS
2018
Structure-activity relationships on cynnamoyl derivatives as inhibitors of p300 Histone acetyltransferase
CHEMMEDCHEM
2017
Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2017
Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
CLINICAL EPIGENETICS
2017
EZH2 inhibitors: a patent review (2014-2016)
EXPERT OPINION ON THERAPEUTIC PATENTS
2017
The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells
ONCOTARGET
2017
Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice
NEUROSCIENCE LETTERS
2017
Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model
AUTOIMMUNITY
2016
Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent
JOURNAL OF MEDICINAL CHEMISTRY
2016
LSD1 inhibitors: a patent review (2010-2015)
EXPERT OPINION ON THERAPEUTIC PATENTS
2016
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells
JOURNAL OF MEDICINAL CHEMISTRY
2016
« prima
< precedente
1
2
3
4
5
seguente ›
ultima »
Progetti di Ricerca
Design and biological evaluation of novel epigenetic dual-targeting modulators to fight cancer
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma